Skip to content

Study · Animal study (in vivo) · rat · 1982

5 results

Neural regulation of gastric acid secretion in rats: influence of dermorphin.

Improta G, Broccardo M, Lisi A, Melchiorri P

Regulatory peptides1 Mar 1982Cited by 15 (Europe PMC)

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study5

5 results from studies that gave the peptide. No result from this study comes from people.

  1. 01AnimalAnimal study (in vivo)Efficacy outcome

    In pylorus-ligated rats, intracerebroventricular dermorphin dose-dependently suppressed water distension-stimulated gastric acid output.

    In plain wordsIn rats, brain injections of dermorphin reduced stomach acid output stimulated by water distension, with a dose-dependent effect.

    Peptide
    Dermorphin
    Outcome
    DecreaseWater distension-stimulated gastric acid output
    Study

    ratn: not reported in source

    conscious pylorus-ligated rats
    Outcome group
    Gastrointestinal function · Gastrointestinal
    Studied dose
    threshold 5 pmol . kg-1 · intracerebroventricularAs given in this study (rat).

    Source sentences

    Summary
    Dermorphin injected i.c.v. suppressed the stimulation of gastric acid output by gastric water distension and this effect is dose-dependent, the threshold dose being 5 pmol . kg-1.
    1 context sentence
    Summary · context
    The effects of subcutaneous (s.c.) and intracerebroventricular (i.c.v.) injections of dermorphin on gastric acid output both basal and stimulated by water distension of the stomach, insulin or histamine injections, were studied in conscious pylorus-ligated rats.
  2. 02AnimalAnimal study (in vivo)Efficacy outcome

    In pylorus-ligated rats, dermorphin partially blocked insulin-stimulated gastric secretion.

    In plain wordsIn rats, dermorphin partly blocked stomach secretion stimulated by insulin.

    Peptide
    Dermorphin
    Outcome
    DecreaseInsulin-stimulated gastric secretion
    Study

    ratn: not reported in source

    conscious pylorus-ligated rats
    Outcome group
    Gastrointestinal function · Gastrointestinal
    Studied dose
    Dose not stated

    Source sentences

    Summary
    Insulin stimulated gastric secretion is partially blocked by the peptide.
    1 context sentence
    Summary · context
    The effects of subcutaneous (s.c.) and intracerebroventricular (i.c.v.) injections of dermorphin on gastric acid output both basal and stimulated by water distension of the stomach, insulin or histamine injections, were studied in conscious pylorus-ligated rats.
  3. 03AnimalAnimal study (in vivo)Efficacy outcome

    In pylorus-ligated rats, subcutaneous dermorphin inhibited basal gastric secretion.

    In plain wordsIn rats, dermorphin injections under the skin reduced basal stomach secretion.

    Peptide
    Dermorphin
    Outcome
    DecreaseBasal gastric secretion
    Study

    ratn: not reported in source

    conscious pylorus-ligated rats
    Outcome group
    Gastrointestinal function · Gastrointestinal
    Studied dose
    625 nmol . kg-1 · subcutaneousAs given in this study (rat).

    Source sentences

    Summary
    Subcutaneous injections of dermorphin, at a dose of 625 nmol . kg-1, inhibited basal and water distension-induced gastric secretion.
    1 context sentence
    Summary · context
    The effects of subcutaneous (s.c.) and intracerebroventricular (i.c.v.) injections of dermorphin on gastric acid output both basal and stimulated by water distension of the stomach, insulin or histamine injections, were studied in conscious pylorus-ligated rats.
  4. 04AnimalAnimal study (in vivo)Efficacy outcome

    In pylorus-ligated rats, subcutaneous dermorphin inhibited water distension-induced gastric secretion.

    In plain wordsIn rats, dermorphin injections under the skin reduced stomach secretion stimulated by water distension.

    Peptide
    Dermorphin
    Outcome
    DecreaseWater distension-induced gastric secretion
    Study

    ratn: not reported in source

    conscious pylorus-ligated rats
    Outcome group
    Gastrointestinal function · Gastrointestinal
    Studied dose
    625 nmol . kg-1 · subcutaneousAs given in this study (rat).

    Source sentences

    Summary
    Subcutaneous injections of dermorphin, at a dose of 625 nmol . kg-1, inhibited basal and water distension-induced gastric secretion.
    1 context sentence
    Summary · context
    The effects of subcutaneous (s.c.) and intracerebroventricular (i.c.v.) injections of dermorphin on gastric acid output both basal and stimulated by water distension of the stomach, insulin or histamine injections, were studied in conscious pylorus-ligated rats.
  5. 05AnimalAnimal study (in vivo)Efficacy outcome

    In pylorus-ligated rats, intracerebroventricular dermorphin did not affect histamine-induced gastric secretion.

    In plain wordsIn rats, brain injections of dermorphin did not affect stomach secretion stimulated by histamine.

    Peptide
    Dermorphin
    Outcome
    No significant changeHistamine-induced gastric secretion
    Study

    ratn: not reported in source

    conscious pylorus-ligated rats
    Outcome group
    Gastrointestinal function · Gastrointestinal
    Studied dose
    Dose not stated · intracerebroventricularAs given in this study (rat).

    Source sentences

    Summary
    Injections (i.c.v.) of dermorphin were ineffective on histamine-induced gastric secretion.
    1 context sentence
    Summary · context
    The effects of subcutaneous (s.c.) and intracerebroventricular (i.c.v.) injections of dermorphin on gastric acid output both basal and stimulated by water distension of the stomach, insulin or histamine injections, were studied in conscious pylorus-ligated rats.

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 2Current

    27 Oct 2026, 18:20 UTC

    Study results updated

  2. Version 1

    27 Oct 2026, 16:32 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

PepBank is a research reference. Talk to a doctor before you use any peptide.